Who owns Novartis Ag Namen Akt?
- Ticker: NVSEF
- CUSIP Number: h5820q150
Tip: Access positions for across all investors
Analyze quarterly positions in Novartis Ag Namen Akt with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Novartis Ag Namen Akt stock
Who bought or sold Novartis Ag Namen Akt this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Boston Common Asset Management | 125k | $12M | -3% | Mar 2024 |
|
| Kennedy Capital Management | 67k | $6.5M | 190% | Mar 2024 |
|
| Promethos Capital | 1.4k | $135k | 100% | Mar 2024 |
|
Who sold out of Novartis Ag Namen Akt?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Reed Conner & Birdwell | Sep 2023 | 484k | $50M |
| Partners Capital Investment Group | Dec 2023 | 58k | $5.9M |
| Monticello Wealth Management | Dec 2023 | 2.4k | $238k |